ABBV-400, Bevacizumab, Folinic Acid, Fluorouracil — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-12 (month) in 4mo
ESTIMATED |
READOUT
Study to Assess Adverse Events and Change in Disease Activity in Previously Trea
Phase 2 · Unresectable Metastatic Colorectal Cancer |
ABBV AbbVie Inc. | ABBV-400, Bevacizumab, Folinic Acid, Flu |
ClinicalTrials.gov ↗
✓ Source-checked 2026-08-06
Sponsor-projected date — can change
|